{"id":1300,"date":"2019-01-16T12:55:32","date_gmt":"2019-01-16T12:55:32","guid":{"rendered":"https:\/\/vs-a.fr\/?p=1300"},"modified":"2019-01-23T12:59:16","modified_gmt":"2019-01-23T12:59:16","slug":"viguie-schmidt-associes-has-advised-lfb","status":"publish","type":"post","link":"https:\/\/vs-a.fr\/en\/viguie-schmidt-associes-has-advised-lfb\/","title":{"rendered":"Vigui\u00e9 Schmidt &#038; Associ\u00e9s has advised LFB"},"content":{"rendered":"<p>Vigui\u00e9 Schmidt &amp; Associ\u00e9s advised LFB, which enters into exclusive negotiations with Novartis regarding the proposed sale of CellforCure, a leading pharmaceutical establishment that specializes in the industrialization, process optimization and large scale GMP manufacturing of various cell and gene therapy products for bio-pharmaceutical companies.<\/p>\n<p>Members of the team involved in the transaction:<\/p>\n<ul>\n<li><a href=\"\/?p=657\">Fran\u00e7ois Bourrier-Soifer<\/a><\/li>\n<li><a href=\"\/?p=641\">Christel Alberti<\/a><\/li>\n<li><a href=\"https:\/\/vs-a.fr\/en\/team\/etienne-gouesse\/\">Etienne Gouesse<\/a><\/li>\n<li><a href=\"\/?p=687\">Alexandre Piette<\/a><\/li>\n<li><a href=\"\/?p=685\">Camille Pedrini<\/a><\/li>\n<li><a href=\"\/?p=665\">Maxence Dubois<\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/vs-a.fr\/wp-content\/uploads\/2019\/01\/VSA-conseille-le-groupe-LFB_ODA-16-janv-2019.pdf\">Download the press release<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vigui\u00e9 Schmidt &amp; Associ\u00e9s advised LFB, which enters into exclusive negotiations with Novartis regarding the proposed sale of CellforCure, a leading pharmaceutical establishment that specializes in the industrialization, process optimization and large scale GMP manufacturing of various cell and gene therapy products for bio-pharmaceutical companies. Members of the team involved in the transaction: Fran\u00e7ois Bourrier-Soifer&#8230;  <a class=\"excerpt-read-more\" href=\"https:\/\/vs-a.fr\/en\/viguie-schmidt-associes-has-advised-lfb\/\" title=\"Read Vigui\u00e9 Schmidt &#038; Associ\u00e9s has advised LFB\">Read more &raquo;<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-1300","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"_links":{"self":[{"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/posts\/1300","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/comments?post=1300"}],"version-history":[{"count":2,"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/posts\/1300\/revisions"}],"predecessor-version":[{"id":1302,"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/posts\/1300\/revisions\/1302"}],"wp:attachment":[{"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/media?parent=1300"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/categories?post=1300"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/tags?post=1300"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}